Registration for a live webinar on 'Innovations in antibiotic discovery: combating resistant infections' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Epidemiology and risk factors
-
1. Epidemiology of COPD
- Dr. David Mannino
-
2. COPD in never smokers
- Dr. Sundeep Salvi
-
3. Genetics of chronic obstructive pulmonary disease (COPD)
- Prof. Martin Tobin
- Phenotypes of COPD
-
4. COPD and asthma: similarities and differences
- Prof. Peter Barnes
- Pathophysiology and mechanisms of COPD
-
5. The pathology of chronic obstructive pulmonary disease
- Prof. James Hogg
-
6. The continuum of COPD: a physiological perspective
- Prof. Denis O'Donnell
-
7. Inflammatory and immune mechanisms in COPD
- Prof. Peter Barnes
-
8. Mechanisms of COPD exacerbations and relation to exacerbation therapy
- Prof. Wisia Wedzicha
-
9. Protease-antiprotease balance
- Prof. Robert Stockley
- Therapy and management
-
10. Updates in chronic obstructive pulmonary disease (COPD)
- Dr. Omar S. Usmani
-
11. Long-acting bronchodilators in COPD
- Prof. Bart Celli
-
12. Treatment of COPD exacerbations
- Prof. Antonio Anzueto
-
13. Pulmonary rehabilitation: history, promise and problems
- Prof. Richard Casaburi
-
14. Lung volume reduction: advances in COPD
- Dr. Nick Hopkinson
-
15. New pharmacological therapies for COPD
- Prof. Peter Barnes
-
16. The Salford lung study in COPD
- Dr. Dave Leather
- COPD case studies
-
17. COPD treatment case I: COPD with “bronchitis attacks”
- Dr. Janwillem Kocks
-
18. COPD treatment case II: COPD with asthma as child
- Dr. Janwillem Kocks
-
19. COPD treatment case III: COPD with pre-diabetes
- Dr. Janwillem Kocks
-
20. Tailoring care for advanced COPD
- Prof. Wissam Chatila
- Archived Lectures *These may not cover the latest advances in the field
-
21. Alpha-1 antitrypsin deficiency: state of the art
- Dr. Jamie Stoller
-
22. Oxidative stress in COPD
- Prof. William MacNee
-
23. Managing co-morbidity in COPD
- Dr. John Hurst
-
24. Clinical phenotypes of COPD
- Prof. Jørgen Vestbo
-
25. Pulmonary rehabilitation: focusing on rehabilitative exercise
- Prof. Richard Casaburi
-
26. Genetics of COPD
- Prof. Ian Hall
Printable Handouts
Navigable Slide Index
Topics Covered
- Asthma-COPD overlap syndrome
- LAMA in asthma
- Case management
- An updated version, which will include the latest GOLD COPD recommendations, will be released in November 2017
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kocks, J. (2016, February 29). COPD treatment case II: COPD with asthma as child [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved May 9, 2025, from https://doi.org/10.69645/KAQX8227.Export Citation (RIS)
Publication History
- Published on February 29, 2016
Financial Disclosures
- Dr. Janwillem Kocks has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Respiratory Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
Hi.
This is the second of
the COPD treatment cases.
I'm Janwillem Kocks.
I'm a general practitioner
and an assistant professor
at the Department
of General Practice
at the University Medical Center
in Groningen in the Netherlands.
And this case will be about
a COPD patient with asthma.
0:20
So we start with Mrs. D again.
She's a 59-year-old lady and
works in a community archive.
And she tells you that she
noticed that while carrying
boxes with books
and stuff has become
more difficult in the last months.
And you see her for the annual
review, which you do for COPD.
If you look at
the lung function,
it's quite stable in the last years,
with an FEV1 of 74% of predicted,
and a FEV1/FVC of 60%.
She tells you she had a course
of antibiotics for a lung attack
last month in the
out-of-hours GP service.
You can question if antibiotics
is the best treatment option,
but this is what she tells you.
She stopped smoking four weeks ago
after about 30 years of smoking,
and it adds up to 35 pack years.
She's got a BMI of 27.8
and a CCQ score of 1.8.
And the medication she uses
is ipratropium short-acting,
a muscarinic antagonist.
And last week she's been using
that for about three times a day
during her work and
when walking with friends.
Next is she uses
tiotropium one times a day.
And if you go back to her
and talk to her a bit longer
about her history she had
with her lung complains,
she says she was admitted to
a rehabilitation service for her CARA,
as she calls it in Dutch,
when she was seven.
The Dutch rehabilitation center
for asthma in Davos, Switzerland.
It's nice, high in
the mountains which
makes it less of a host of
mites and other things that
is bad for young asthma patients.
And it's still in use
for asthma patients.
So that's an important
new information,
and it's different
from the information
we had for the previous case.
And as she completed
the CCQ questionnaire.